Pharmacokinetic analysis of new synthetic antimalarial N-251
Abstract Background With the emergence and growing number of drug-resistant Plasmodium falciparum, a new drug for malaria control must be urgently developed. The new antimalarial synthetic compound N-251 was recently discovered. As an endoperoxide structure in the body, the compound shows high antim...
Published in: | Tropical Medicine and Health |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
BMC
2019
|
Subjects: | |
Online Access: | https://doi.org/10.1186/s41182-019-0167-4 https://doaj.org/article/1c3bc96a0ba447b9baec280628cbbb1c |
id |
ftdoajarticles:oai:doaj.org/article:1c3bc96a0ba447b9baec280628cbbb1c |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:1c3bc96a0ba447b9baec280628cbbb1c 2023-05-15T15:17:58+02:00 Pharmacokinetic analysis of new synthetic antimalarial N-251 Kazuaki Okada Akira Sato Akiko Hiramoto Rena Isogawa Yuji Kurosaki Kazutaka Higaki Shin-Ichi Miyoshi Kyung-Soo Chang Hye-Sook Kim 2019-07-01T00:00:00Z https://doi.org/10.1186/s41182-019-0167-4 https://doaj.org/article/1c3bc96a0ba447b9baec280628cbbb1c EN eng BMC http://link.springer.com/article/10.1186/s41182-019-0167-4 https://doaj.org/toc/1349-4147 doi:10.1186/s41182-019-0167-4 1349-4147 https://doaj.org/article/1c3bc96a0ba447b9baec280628cbbb1c Tropical Medicine and Health, Vol 47, Iss 1, Pp 1-8 (2019) Synthetic endoperoxide 6-(1,2,6,7-tetraoxaspiro [7.11] nonadec-4-yl)hexan-1-ol (N-251) Pharmacokinetic (PK) study Bioavailability (F) Antimalarial medicine Arctic medicine. Tropical medicine RC955-962 article 2019 ftdoajarticles https://doi.org/10.1186/s41182-019-0167-4 2022-12-31T02:45:20Z Abstract Background With the emergence and growing number of drug-resistant Plasmodium falciparum, a new drug for malaria control must be urgently developed. The new antimalarial synthetic compound N-251 was recently discovered. As an endoperoxide structure in the body, the compound shows high antimalarial activity and curative effects. We performed a pharmacokinetic (PK) analysis of N-251 under various conditions using mice to understand the inhibitory effect of N-251 in parasite-infected mice. Results PK study of N-251 after intravenous and oral administration in mice showed plasma concentration of N-251 was decreased drastically by intravenous route. C max was reached in 2 h after oral administration of N-251, and the level decreased to a level similar to that obtained after intravenous administration. The area under the curves (AUCs) of the plasma concentration of N-251 increased dose-proportionally in both administrations, and bioavailability (F) was approximately 23%. Additionally, T max, C max, AUC, and F increased in fasted mice compared to normal-fed mice after the administration of N-251, indicating the influence of diet on the absorption kinetics of N-251. Furthermore, in parasite-infected fasted mice, the plasma concentration-time profile of N-251 was similar to that in normal-fasted mice. Based on the PK parameters of single oral administration of N-251, we investigated the effect of multiple oral doses of N-251 (68 mg/kg three times per day for 2 days) in normal-fed mice. The plasma concentration of N-251 was between 10 and 1000 ng/mL. The simulation curve calculated based on the PK parameters obtained from the single-dose study well described the plasma concentrations after multiple oral dosing, indicating that N-251 did not accumulate in the mice. Multiple oral administrations of N-251 in mice were required to completely eliminate parasites without accumulation of N-251. Conclusions N-251 has been selected as a potent antimalarial candidate. We found that N-251 showed short half-life in plasma, ... Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Tropical Medicine and Health 47 1 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
Synthetic endoperoxide 6-(1,2,6,7-tetraoxaspiro [7.11] nonadec-4-yl)hexan-1-ol (N-251) Pharmacokinetic (PK) study Bioavailability (F) Antimalarial medicine Arctic medicine. Tropical medicine RC955-962 |
spellingShingle |
Synthetic endoperoxide 6-(1,2,6,7-tetraoxaspiro [7.11] nonadec-4-yl)hexan-1-ol (N-251) Pharmacokinetic (PK) study Bioavailability (F) Antimalarial medicine Arctic medicine. Tropical medicine RC955-962 Kazuaki Okada Akira Sato Akiko Hiramoto Rena Isogawa Yuji Kurosaki Kazutaka Higaki Shin-Ichi Miyoshi Kyung-Soo Chang Hye-Sook Kim Pharmacokinetic analysis of new synthetic antimalarial N-251 |
topic_facet |
Synthetic endoperoxide 6-(1,2,6,7-tetraoxaspiro [7.11] nonadec-4-yl)hexan-1-ol (N-251) Pharmacokinetic (PK) study Bioavailability (F) Antimalarial medicine Arctic medicine. Tropical medicine RC955-962 |
description |
Abstract Background With the emergence and growing number of drug-resistant Plasmodium falciparum, a new drug for malaria control must be urgently developed. The new antimalarial synthetic compound N-251 was recently discovered. As an endoperoxide structure in the body, the compound shows high antimalarial activity and curative effects. We performed a pharmacokinetic (PK) analysis of N-251 under various conditions using mice to understand the inhibitory effect of N-251 in parasite-infected mice. Results PK study of N-251 after intravenous and oral administration in mice showed plasma concentration of N-251 was decreased drastically by intravenous route. C max was reached in 2 h after oral administration of N-251, and the level decreased to a level similar to that obtained after intravenous administration. The area under the curves (AUCs) of the plasma concentration of N-251 increased dose-proportionally in both administrations, and bioavailability (F) was approximately 23%. Additionally, T max, C max, AUC, and F increased in fasted mice compared to normal-fed mice after the administration of N-251, indicating the influence of diet on the absorption kinetics of N-251. Furthermore, in parasite-infected fasted mice, the plasma concentration-time profile of N-251 was similar to that in normal-fasted mice. Based on the PK parameters of single oral administration of N-251, we investigated the effect of multiple oral doses of N-251 (68 mg/kg three times per day for 2 days) in normal-fed mice. The plasma concentration of N-251 was between 10 and 1000 ng/mL. The simulation curve calculated based on the PK parameters obtained from the single-dose study well described the plasma concentrations after multiple oral dosing, indicating that N-251 did not accumulate in the mice. Multiple oral administrations of N-251 in mice were required to completely eliminate parasites without accumulation of N-251. Conclusions N-251 has been selected as a potent antimalarial candidate. We found that N-251 showed short half-life in plasma, ... |
format |
Article in Journal/Newspaper |
author |
Kazuaki Okada Akira Sato Akiko Hiramoto Rena Isogawa Yuji Kurosaki Kazutaka Higaki Shin-Ichi Miyoshi Kyung-Soo Chang Hye-Sook Kim |
author_facet |
Kazuaki Okada Akira Sato Akiko Hiramoto Rena Isogawa Yuji Kurosaki Kazutaka Higaki Shin-Ichi Miyoshi Kyung-Soo Chang Hye-Sook Kim |
author_sort |
Kazuaki Okada |
title |
Pharmacokinetic analysis of new synthetic antimalarial N-251 |
title_short |
Pharmacokinetic analysis of new synthetic antimalarial N-251 |
title_full |
Pharmacokinetic analysis of new synthetic antimalarial N-251 |
title_fullStr |
Pharmacokinetic analysis of new synthetic antimalarial N-251 |
title_full_unstemmed |
Pharmacokinetic analysis of new synthetic antimalarial N-251 |
title_sort |
pharmacokinetic analysis of new synthetic antimalarial n-251 |
publisher |
BMC |
publishDate |
2019 |
url |
https://doi.org/10.1186/s41182-019-0167-4 https://doaj.org/article/1c3bc96a0ba447b9baec280628cbbb1c |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
Tropical Medicine and Health, Vol 47, Iss 1, Pp 1-8 (2019) |
op_relation |
http://link.springer.com/article/10.1186/s41182-019-0167-4 https://doaj.org/toc/1349-4147 doi:10.1186/s41182-019-0167-4 1349-4147 https://doaj.org/article/1c3bc96a0ba447b9baec280628cbbb1c |
op_doi |
https://doi.org/10.1186/s41182-019-0167-4 |
container_title |
Tropical Medicine and Health |
container_volume |
47 |
container_issue |
1 |
_version_ |
1766348215005741056 |